NF−κB can exert anti−tumor properties by promoting cellular death through the suppression of anti−apoptotic genes, synergizing with tumor suppressors such as p53, reducing cellular proliferation by inhibiting JNK, and resolving inflammation in later stages [36]. The gene discussed is MAPK8; the disease is neoplasm.